To this purpose, the present study investigates the role of pluripotency factors NANOG, SOX2, and OCT4 in a large homogeneous cohort of 348 HNSCC patients to ascertain their potential impact on patient prognosis and disease outcome. This evidence concerns the gene NANOG and head and neck squamous cell carcinoma.